<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00815269</url>
  </required_header>
  <id_info>
    <org_study_id>NMU-200812-MZ39</org_study_id>
    <secondary_id>NJFY0812015</secondary_id>
    <nct_id>NCT00815269</nct_id>
  </id_info>
  <brief_title>Vasodilation Effect of Inhalational Anesthetics</brief_title>
  <acronym>VEFIHA</acronym>
  <official_title>Vasodilation Effect of Inhalational Anesthetics Including Halothane, Isoflurane, Sevoflurane, Desflurane and Enflurane</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Previous studies on animals suggest that inhalational anesthetics can reduce vascular tension
      in vitro resulting in vasodilation and decrease in blood pressure. This role for inhalational
      anesthetics has essential clinical implications such as the condition of sepsis or septic
      shock or other shock-associated states during which the blood vessel constricts strongly and
      leads to circulation dysfunction. The vasodilation property of these anesthetics including
      halothane, isoflurane, sevoflurane, desflurane and enflurane enables them to be better
      options than other general anesthetics in many clinical conditions needing the vasculature to
      be dilated. The investigators hypothesized that these inhalational anesthetics can evoke
      vasodilation measured with ultrasonography during general anesthesia in vivo as the in vitro
      studies displayed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ultrasonography of blood vessels including radial artery, brachial artery, femoral artery, popliteal artery</measure>
    <time_frame>Ten min prior to anesthesia; 0 min of anesthesia; 0 min of the end of anesthesia induction; 5, 10, 20, 30, 60 min during maintenance of the anesthesia</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood flow volume during anesthesia of the vasculature</measure>
    <time_frame>Ten min prior to anesthesia; 0 min of anesthesia; 0 min of the end of anesthesia induction; 5, 10, 20, 30, 60 min during maintenance of the anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure including systolic, diastolic and mean artery blood pressures</measure>
    <time_frame>Ten min prior to anesthesia; 0 min of anesthesia; 0 min of the end of anesthesia induction; 5, 10, 20, 30, 60 min during maintenance of the anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The time interval of between the initiation of the inhalational anesthetics delivered to the beginning of decreasing of blood pressure</measure>
    <time_frame>From the beginning of anesthesia (0 min) till the first time of blood pressure decreased, this measure would be varied according to different individuals</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The total dose of phenylephrine required to maintain baseline arterial blood pressure</measure>
    <time_frame>From the beginning of anesthesia (0 min) to 20 min after anesthesia begun</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regression and correlation analyses between different doses of the anesthetics and the extent of vasodilation</measure>
    <time_frame>Forty eight hours after operation</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>General Anesthesia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Halothane anesthesia: induction and maintenance with different doses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Isoflurane anesthesia: induction and maintenance with different doses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sevoflurane anesthesia: induction and maintenance with different doses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Desflurane anesthesia: induction and maintenance with different doses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Enflurane anesthesia: induction and maintenance with different doses</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Halothane</intervention_name>
    <description>Induction: 2-4% halothane pluses 3-5 L/min oxygen Maintenance: different doses from 0.5% to 3% with 1-2 L/min oxygen</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Fluothane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isoflurane</intervention_name>
    <description>Induction: 2-5% isoflurane pluses 3-5 L/min oxygen Maintenance: different doses from 1% to 4% with 1-2 L/min oxygen</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Forane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Induction: 3-8% sevoflurane pluses 3-5 L/min oxygen Maintenance: different doses from 1% to 4% with 1-2 L/min oxygen</description>
    <arm_group_label>3</arm_group_label>
    <other_name>Sevorane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane</intervention_name>
    <description>Induction: 2-8% desflurane pluses 3-5 L/min oxygen Maintenance: different doses from 1% to 4% with 1-2 L/min oxygen</description>
    <arm_group_label>4</arm_group_label>
    <other_name>Suprane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Enflurane</intervention_name>
    <description>Induction: 2-5% enflurane pluses 3-5 L/min oxygen Maintenance: different doses from 1% to 4% with 1-2 L/min oxygen</description>
    <arm_group_label>5</arm_group_label>
    <other_name>Ethrane</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be undergoing general anesthesia

          -  Age between 19-45 years

        Exclusion Criteria:

          -  With hypertension

          -  Existing organic dysfunction

          -  Allergic to inhalant anesthetics

          -  Alcohol addictive or narcotic dependent patients

          -  A history of the use of centrally-acting drugs of any sort, chronic pain and
             psychiatric diseases records
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>XiaoFeng Shen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Nanjing Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nanjing Maternal and Child Health Care Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 26, 2008</study_first_submitted>
  <study_first_submitted_qc>December 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2008</study_first_posted>
  <last_update_submitted>December 22, 2009</last_update_submitted>
  <last_update_submitted_qc>December 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2009</last_update_posted>
  <responsible_party>
    <name_title>XiaoFeng Shen</name_title>
    <organization>Nanjing Medical University</organization>
  </responsible_party>
  <keyword>Inhalant anesthetic</keyword>
  <keyword>Vasodilation</keyword>
  <keyword>General anesthesia</keyword>
  <keyword>Ultrasonography</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
    <mesh_term>Halothane</mesh_term>
    <mesh_term>Enflurane</mesh_term>
    <mesh_term>Anesthetics, Inhalation</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

